Watch sustainability champions reveal key solutions, innovations accelerating India's SDGs at ‘The Sustainability 100+ Dialogues 2021’-Haryana Roundtable on March 5 at 12pm

Hold Sun Pharmaceutical Industries target of Rs 460: Sharekhan

Sharekhan recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 460 in its research report dated November 13, 2019.

November 14, 2019 / 11:43 AM IST
  • bselive
  • nselive
Todays L/H

Sharekhan's research report on Sun Pharmaceutical Industries

Sun Pharma’s Q2FY2020 results are in line with estimates. Staggered penetration of specialty portfolio, higher specialty promotional spends, increasing R&D, and continued pricing issues in the U.S. are likely to be the key challenge for earnings growth We expect the company to report sales and profit CAGR of 14% and 22%, respectively, over the next two years.


We maintain Hold rating on Sun Pharma with a revised PT of Rs 460.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Nov 14, 2019 11:43 am

stay updated

Get Daily News on your Browser